CA
AUTL

Cetera Advisors’s Autolus Therapeutics AUTL Stock Holding History

Cetera Advisors’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$839K Buy
+131,500
New +$820K 0.01% 1242

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cetera Advisors's AUTL Position: Q1 2024 in Review

Cetera Advisors opened a new position in Autolus Therapeutics (AUTL) in Q1 2024: 131,500 shares worth $839K. The stake represents 0.01% of the portfolio and ranks #1242 among its holdings.

121 funds tracked by Wall St. Rank hold AUTL as of Q1 2024.

  • Cetera Advisors held 131,500 shares of Autolus Therapeutics worth $839K as of Q1 2024.
  • Autolus Therapeutics was a new Cetera Advisors position in Q1 2024.
  • Autolus Therapeutics made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1242 holding.
  • 121 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.